Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1326 entries
Sorted by: Best Match Show Resources per page
[Discussion: on studies of clinical nursing - a theoretical image and the true status].

Kango kenkyu. The Japanese journal of nursing research

Ujiie S, Takahashi R, Hattori H, Fujisawa Y, Sugimori K.
PMID: 253805
Kango Kenkyu. 1979;12(2):123-34.

No abstract available.

Cite
Ujiie S, Takahashi R, Hattori H, et al. [Discussion: on studies of clinical nursing - a theoretical image and the true status]. Kango Kenkyu. 1979;12(2):123-34
Ujiie, S., Takahashi, R., Hattori, H., Fujisawa, Y., & Sugimori, K. (1979). [Discussion: on studies of clinical nursing - a theoretical image and the true status]. Kango kenkyu. The Japanese journal of nursing research, 12(2), 123-34.
Ujiie, S, et al. "[Discussion: on studies of clinical nursing - a theoretical image and the true status]." Kango kenkyu. The Japanese journal of nursing research vol. 12,2 (1979): 123-34.
Ujiie S, Takahashi R, Hattori H, Fujisawa Y, Sugimori K. [Discussion: on studies of clinical nursing - a theoretical image and the true status]. Kango Kenkyu. 1979;12(2):123-34. Japanese. PMID: 253805.
Copy Download .nbib Format: NLM
Effects of pegylated interferon-α-2a monotherapy on growth in Japanese children with chronic hepatitis C.

Hepatology research : the official journal of the Japan Society of Hepatology

Tsunoda T, Inui A, Kawamoto M, Sogo T, Komatsu H, Fujisawa T.
PMID: 23607340
Hepatol Res. 2014 Mar;44(3):251-8. doi: 10.1111/hepr.12118. Epub 2013 Apr 24.

AIM: The relationship between pegylated interferon (PEG IFN)-α-2a and growth of children with chronic hepatitis C (CHC) remains unclear. This study was to evaluate the effects of PEG IFN-α-2a on growth.METHODS: From 2003-2012, we prospectively analyzed the data of...

Cite
Tsunoda T, Inui A, Kawamoto M, et al. Effects of pegylated interferon-α-2a monotherapy on growth in Japanese children with chronic hepatitis C. Hepatol Res. 2013;44(3):251-8doi: 10.1111/hepr.12118.
Tsunoda, T., Inui, A., Kawamoto, M., Sogo, T., Komatsu, H., & Fujisawa, T. (2014). Effects of pegylated interferon-α-2a monotherapy on growth in Japanese children with chronic hepatitis C. Hepatology research : the official journal of the Japan Society of Hepatology, 44(3), 251-8. https://doi.org/10.1111/hepr.12118
Tsunoda, Tomoyuki, et al. "Effects of pegylated interferon-α-2a monotherapy on growth in Japanese children with chronic hepatitis C." Hepatology research : the official journal of the Japan Society of Hepatology vol. 44,3 (2014): 251-8. doi: https://doi.org/10.1111/hepr.12118
Tsunoda T, Inui A, Kawamoto M, Sogo T, Komatsu H, Fujisawa T. Effects of pegylated interferon-α-2a monotherapy on growth in Japanese children with chronic hepatitis C. Hepatol Res. 2014 Mar;44(3):251-8. doi: 10.1111/hepr.12118. Epub 2013 Apr 24. PMID: 23607340.
Copy Download .nbib Format: NLM
Thiophene-Fused π-Systems from Diarylacetylenes and Elemental Sulfur.

Journal of the American Chemical Society

Meng L, Fujikawa T, Kuwayama M, Segawa Y, Itami K.
PMID: 27501373
J Am Chem Soc. 2016 Aug 17;138(32):10351-5. doi: 10.1021/jacs.6b06486. Epub 2016 Aug 08.

A simple yet effective method for the formation of thiophene-fused π-systems is reported. When arylethynyl-substituted polycyclic arenes were heated in DMF in the presence of elemental sulfur, the corresponding thiophene-fused polycyclic arenes were obtained via cleavage of the ortho-C-H...

Cite
Meng L, Fujikawa T, Kuwayama M, et al. Thiophene-Fused π-Systems from Diarylacetylenes and Elemental Sulfur. J Am Chem Soc. 2016;138(32):10351-5doi: 10.1021/jacs.6b06486.
Meng, L., Fujikawa, T., Kuwayama, M., Segawa, Y., & Itami, K. (2016). Thiophene-Fused π-Systems from Diarylacetylenes and Elemental Sulfur. Journal of the American Chemical Society, 138(32), 10351-5. https://doi.org/10.1021/jacs.6b06486
Meng, Lingkui, et al. "Thiophene-Fused π-Systems from Diarylacetylenes and Elemental Sulfur." Journal of the American Chemical Society vol. 138,32 (2016): 10351-5. doi: https://doi.org/10.1021/jacs.6b06486
Meng L, Fujikawa T, Kuwayama M, Segawa Y, Itami K. Thiophene-Fused π-Systems from Diarylacetylenes and Elemental Sulfur. J Am Chem Soc. 2016 Aug 17;138(32):10351-5. doi: 10.1021/jacs.6b06486. Epub 2016 Aug 08. PMID: 27501373.
Copy Download .nbib Format: NLM
Postural optimization during functional reach while kneeling and standing.

Journal of physical therapy science

Fujisawa H, Suzuki H, Kawakami S, Murakami K, Suzuki M.
PMID: 27630433
J Phys Ther Sci. 2016 Aug;28(8):2362-8. doi: 10.1589/jpts.28.2362. Epub 2016 Aug 31.

[Purpose] The purpose of the present study was to examine the validity of functional reach models by comparing actual values with estimated values. [Subjects and Methods] Twenty-eight volunteers were included in this study (male: 14, female: 14, age: 21...

Cite
Fujisawa H, Suzuki H, Kawakami S, et al. Postural optimization during functional reach while kneeling and standing. J Phys Ther Sci. 2016;28(8):2362-8doi: 10.1589/jpts.28.2362.
Fujisawa, H., Suzuki, H., Kawakami, S., Murakami, K., & Suzuki, M. (2016). Postural optimization during functional reach while kneeling and standing. Journal of physical therapy science, 28(8), 2362-8. https://doi.org/10.1589/jpts.28.2362
Fujisawa, Hiroyuki, et al. "Postural optimization during functional reach while kneeling and standing." Journal of physical therapy science vol. 28,8 (2016): 2362-8. doi: https://doi.org/10.1589/jpts.28.2362
Fujisawa H, Suzuki H, Kawakami S, Murakami K, Suzuki M. Postural optimization during functional reach while kneeling and standing. J Phys Ther Sci. 2016 Aug;28(8):2362-8. doi: 10.1589/jpts.28.2362. Epub 2016 Aug 31. PMID: 27630433; PMCID: PMC5011597.
Copy Download .nbib Format: NLM
A Safety and Efficacy Study of Medium-Dose Etoposide, Cyclophosphamide and Total Body Irradiation Conditioning Before Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia.

Transplantation direct

Shigematsu A, Ozawa Y, Onizuka M, Fujisawa S, Suzuki R, Atsuta Y, Hatanaka K, Masuko M, Ito T, Kobayashi N, Kato J, Miyamura K, Fukuda T, Morishima Y, Imamura M.
PMID: 27500214
Transplant Direct. 2015 Mar 13;1(2):e8. doi: 10.1097/TXD.0000000000000514. eCollection 2015 Mar.

UNLABELLED: Prognosis for adult patients with acute lymphoblastic leukemia (ALL) has been reported to be approximately 35% to 50%, even after allogeneic stem cell transplantation (allo-SCT). We previously reported retrospective analyses of a conditioning regimen of medium-dose etoposide, cyclophosphamide...

Cite
Shigematsu A, Ozawa Y, Onizuka M, et al. A Safety and Efficacy Study of Medium-Dose Etoposide, Cyclophosphamide and Total Body Irradiation Conditioning Before Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia. Transplant Direct. 2015;1(2):e8doi: 10.1097/TXD.0000000000000514.
Shigematsu, A., Ozawa, Y., Onizuka, M., Fujisawa, S., Suzuki, R., Atsuta, Y., Hatanaka, K., Masuko, M., Ito, T., Kobayashi, N., Kato, J., Miyamura, K., Fukuda, T., Morishima, Y., & Imamura, M. (2015). A Safety and Efficacy Study of Medium-Dose Etoposide, Cyclophosphamide and Total Body Irradiation Conditioning Before Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia. Transplantation direct, 1(2), e8. https://doi.org/10.1097/TXD.0000000000000514
Shigematsu, Akio, et al. "A Safety and Efficacy Study of Medium-Dose Etoposide, Cyclophosphamide and Total Body Irradiation Conditioning Before Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia." Transplantation direct vol. 1,2 (2015): e8. doi: https://doi.org/10.1097/TXD.0000000000000514
Shigematsu A, Ozawa Y, Onizuka M, Fujisawa S, Suzuki R, Atsuta Y, Hatanaka K, Masuko M, Ito T, Kobayashi N, Kato J, Miyamura K, Fukuda T, Morishima Y, Imamura M. A Safety and Efficacy Study of Medium-Dose Etoposide, Cyclophosphamide and Total Body Irradiation Conditioning Before Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia. Transplant Direct. 2015 Mar 13;1(2):e8. doi: 10.1097/TXD.0000000000000514. eCollection 2015 Mar. PMID: 27500214; PMCID: PMC4946459.
Copy Download .nbib Format: NLM
Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer.

Annals of surgical oncology

Aoyama T, Kawabe T, Fujikawa H, Hayashi T, Yamada T, Tsuchida K, Yukawa N, Oshima T, Rino Y, Masuda M, Ogata T, Cho H, Yoshikawa T.
PMID: 26170193
Ann Surg Oncol. 2015 Dec;22:S1616. doi: 10.1245/s10434-015-4732-8.

No abstract available.

Cite
Aoyama T, Kawabe T, Fujikawa H, et al. Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer. Ann Surg Oncol. 2015;22:S1616doi: 10.1245/s10434-015-4732-8.
Aoyama, T., Kawabe, T., Fujikawa, H., Hayashi, T., Yamada, T., Tsuchida, K., Yukawa, N., Oshima, T., Rino, Y., Masuda, M., Ogata, T., Cho, H., & Yoshikawa, T. (2015). Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer. Annals of surgical oncology, 22S1616. https://doi.org/10.1245/s10434-015-4732-8
Aoyama, Toru, et al. "Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer." Annals of surgical oncology vol. 22 (2015): S1616. doi: https://doi.org/10.1245/s10434-015-4732-8
Aoyama T, Kawabe T, Fujikawa H, Hayashi T, Yamada T, Tsuchida K, Yukawa N, Oshima T, Rino Y, Masuda M, Ogata T, Cho H, Yoshikawa T. Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer. Ann Surg Oncol. 2015 Dec;22:S1616. doi: 10.1245/s10434-015-4732-8. PMID: 26170193.
Copy Download .nbib Format: NLM
Neonatal Hearing Screening with Otoscopy, Auditory Brain Stem Response, and Otoacoustic Emissions.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery

Doyle KJ, Burggraaff B, Fujikawa S, Kim J, Macarthur CJ.
PMID: 29389264
Otolaryngol Head Neck Surg. 1997 Jun;116(6):597-603. doi: 10.1016/S0194-5998(97)70234-1.

A study was performed to investigate the relationship between external and middle ear factors and hearing screening results by auditory brain stem response (ABR) and transient evoked otoacoustic emissions (EOAEs). The ears of 200 well newborns aged 5 hours...

Cite
Doyle KJ, Burggraaff B, Fujikawa S, et al. Neonatal Hearing Screening with Otoscopy, Auditory Brain Stem Response, and Otoacoustic Emissions. Otolaryngol Head Neck Surg. 1997;116(6):597-603doi: 10.1016/S0194-5998(97)70234-1.
Doyle, K. J., Burggraaff, B., Fujikawa, S., Kim, J., & Macarthur, C. J. (1997). Neonatal Hearing Screening with Otoscopy, Auditory Brain Stem Response, and Otoacoustic Emissions. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 116(6), 597-603. https://doi.org/10.1016/S0194-5998(97)70234-1
Doyle, Karen Jo, et al. "Neonatal Hearing Screening with Otoscopy, Auditory Brain Stem Response, and Otoacoustic Emissions." Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery vol. 116,6 (1997): 597-603. doi: https://doi.org/10.1016/S0194-5998(97)70234-1
Doyle KJ, Burggraaff B, Fujikawa S, Kim J, Macarthur CJ. Neonatal Hearing Screening with Otoscopy, Auditory Brain Stem Response, and Otoacoustic Emissions. Otolaryngol Head Neck Surg. 1997 Jun;116(6):597-603. doi: 10.1016/S0194-5998(97)70234-1. PMID: 29389264.
Copy Download .nbib Format: NLM
Detection of antibiotic resistance genes in the feces of young adult Japanese.

Bioscience of microbiota, food and health

Ohashi Y, Fujisawa T.
PMID: 29038771
Biosci Microbiota Food Health. 2017;36(4):151-154. doi: 10.12938/bmfh.17-004. Epub 2017 Aug 03.

Antibiotic resistance genes in the feces of healthy young adult Japanese were analyzed with polymerase chain reaction using specific primers. Antibiotic resistance genes against macrolides (

Cite
Ohashi Y, Fujisawa T. Detection of antibiotic resistance genes in the feces of young adult Japanese. Biosci Microbiota Food Health. 2017;36(4):151-154doi: 10.12938/bmfh.17-004.
Ohashi, Y., & Fujisawa, T. (2017). Detection of antibiotic resistance genes in the feces of young adult Japanese. Bioscience of microbiota, food and health, 36(4), 151-154. https://doi.org/10.12938/bmfh.17-004
Ohashi, Yuji, and Fujisawa, Tomohiko. "Detection of antibiotic resistance genes in the feces of young adult Japanese." Bioscience of microbiota, food and health vol. 36,4 (2017): 151-154. doi: https://doi.org/10.12938/bmfh.17-004
Ohashi Y, Fujisawa T. Detection of antibiotic resistance genes in the feces of young adult Japanese. Biosci Microbiota Food Health. 2017;36(4):151-154. doi: 10.12938/bmfh.17-004. Epub 2017 Aug 03. PMID: 29038771; PMCID: PMC5633530.
Copy Download .nbib Format: NLM
Analysis of Safety-Related Regulatory Actions for New Drugs in Japan by Nature of Identified Risks.

Pharmaceutical medicine

Fujikawa M, Ono S.
PMID: 29056852
Pharmaceut Med. 2017;31(5):317-327. doi: 10.1007/s40290-017-0198-2. Epub 2017 Jul 13.

BACKGROUND: Mechanisms underlying safety events may be heterogeneous and depend on conditions of development and marketing, including the populations studied in clinical trials and the amount of data required for approval, especially under pathways for accelerated access.OBJECTIVE: This study...

Cite
Fujikawa M, Ono S. Analysis of Safety-Related Regulatory Actions for New Drugs in Japan by Nature of Identified Risks. Pharmaceut Med. 2017;31(5):317-327doi: 10.1007/s40290-017-0198-2.
Fujikawa, M., & Ono, S. (2017). Analysis of Safety-Related Regulatory Actions for New Drugs in Japan by Nature of Identified Risks. Pharmaceutical medicine, 31(5), 317-327. https://doi.org/10.1007/s40290-017-0198-2
Fujikawa, Makoto, and Ono, Shunsuke. "Analysis of Safety-Related Regulatory Actions for New Drugs in Japan by Nature of Identified Risks." Pharmaceutical medicine vol. 31,5 (2017): 317-327. doi: https://doi.org/10.1007/s40290-017-0198-2
Fujikawa M, Ono S. Analysis of Safety-Related Regulatory Actions for New Drugs in Japan by Nature of Identified Risks. Pharmaceut Med. 2017;31(5):317-327. doi: 10.1007/s40290-017-0198-2. Epub 2017 Jul 13. PMID: 29056852; PMCID: PMC5629242.
Copy Download .nbib Format: NLM
Prostaglandin-associated periorbitopathy in latanoprost users.

Clinical ophthalmology (Auckland, N.Z.)

Nakakura S, Yamamoto M, Terao E, Nagatomi N, Matsuo N, Fujisawa Y, Fujio Y, Tabuchi H, Kiuchi Y.
PMID: 25565768
Clin Ophthalmol. 2014 Dec 30;9:51-6. doi: 10.2147/OPTH.S75651. eCollection 2015.

PURPOSE: We investigated the incidence of prostaglandin-associated periorbitopathy (PAP) in subjects with glaucoma treated with latanoprost ophthalmic solution.SUBJECTS AND METHODS: One eye and the forehead in 22 subjects were evaluated. All patients had used latanoprost for more than 1...

Cite
Nakakura S, Yamamoto M, Terao E, et al. Prostaglandin-associated periorbitopathy in latanoprost users. Clin Ophthalmol. 2014;9:51-6doi: 10.2147/OPTH.S75651.
Nakakura, S., Yamamoto, M., Terao, E., Nagatomi, N., Matsuo, N., Fujisawa, Y., Fujio, Y., Tabuchi, H., & Kiuchi, Y. (2015). Prostaglandin-associated periorbitopathy in latanoprost users. Clinical ophthalmology (Auckland, N.Z.), 951-6. https://doi.org/10.2147/OPTH.S75651
Nakakura, Shunsuke, et al. "Prostaglandin-associated periorbitopathy in latanoprost users." Clinical ophthalmology (Auckland, N.Z.) vol. 9 (2015): 51-6. doi: https://doi.org/10.2147/OPTH.S75651
Nakakura S, Yamamoto M, Terao E, Nagatomi N, Matsuo N, Fujisawa Y, Fujio Y, Tabuchi H, Kiuchi Y. Prostaglandin-associated periorbitopathy in latanoprost users. Clin Ophthalmol. 2014 Dec 30;9:51-6. doi: 10.2147/OPTH.S75651. eCollection 2015. PMID: 25565768; PMCID: PMC4284030.
Copy Download .nbib Format: NLM
Significance of ureteroscopic biopsy grade in patients with upper tract urothelial carcinoma.

Current urology

Furukawa J, Miyake H, Sakai I, Fujisawa M.
PMID: 24917735
Curr Urol. 2013 Jan;6(3):156-9. doi: 10.1159/000343531. Epub 2012 Dec 21.

BACKGROUND: The objective of this study was to assess the significance of the ureteroscopic biopsy grade for patients with upper tract urothelial carcinoma (UTUC).PATIENTS AND METHODS: This study included 40 patients who were diagnosed with a single focus of...

Cite
Furukawa J, Miyake H, Sakai I, et al. Significance of ureteroscopic biopsy grade in patients with upper tract urothelial carcinoma. Curr Urol. 2012;6(3):156-9doi: 10.1159/000343531.
Furukawa, J., Miyake, H., Sakai, I., & Fujisawa, M. (2013). Significance of ureteroscopic biopsy grade in patients with upper tract urothelial carcinoma. Current urology, 6(3), 156-9. https://doi.org/10.1159/000343531
Furukawa, Junya, et al. "Significance of ureteroscopic biopsy grade in patients with upper tract urothelial carcinoma." Current urology vol. 6,3 (2013): 156-9. doi: https://doi.org/10.1159/000343531
Furukawa J, Miyake H, Sakai I, Fujisawa M. Significance of ureteroscopic biopsy grade in patients with upper tract urothelial carcinoma. Curr Urol. 2013 Jan;6(3):156-9. doi: 10.1159/000343531. Epub 2012 Dec 21. PMID: 24917735; PMCID: PMC3783279.
Copy Download .nbib Format: NLM
Differentiation of malignant tumours from granulomas by using dynamic [(18)F]-fluoro-L-α-methyltyrosine positron emission tomography.

EJNMMI research

Yamaguchi A, Hanaoka H, Fujisawa Y, Zhao S, Suzue K, Morita A, Tominaga H, Higuchi T, Hisaeda H, Tsushima Y, Kuge Y, Iida Y.
PMID: 25977883
EJNMMI Res. 2015 Apr 30;5:29. doi: 10.1186/s13550-015-0109-z. eCollection 2015.

BACKGROUND: Previous clinical studies have revealed the potential of [(18)F]-fluoro-L-α-methyltyrosine ((18)F-FAMT) for the differential diagnosis of malignant tumours from sarcoidosis. However, one concern regarding the differential diagnosis with (18)F-FAMT is the possibility of false negatives given the small absolute...

Cite
Yamaguchi A, Hanaoka H, Fujisawa Y, et al. Differentiation of malignant tumours from granulomas by using dynamic [(18)F]-fluoro-L-α-methyltyrosine positron emission tomography. EJNMMI Res. 2015;5:29doi: 10.1186/s13550-015-0109-z.
Yamaguchi, A., Hanaoka, H., Fujisawa, Y., Zhao, S., Suzue, K., Morita, A., Tominaga, H., Higuchi, T., Hisaeda, H., Tsushima, Y., Kuge, Y., & Iida, Y. (2015). Differentiation of malignant tumours from granulomas by using dynamic [(18)F]-fluoro-L-α-methyltyrosine positron emission tomography. EJNMMI research, 529. https://doi.org/10.1186/s13550-015-0109-z
Yamaguchi, Aiko, et al. "Differentiation of malignant tumours from granulomas by using dynamic [(18)F]-fluoro-L-α-methyltyrosine positron emission tomography." EJNMMI research vol. 5 (2015): 29. doi: https://doi.org/10.1186/s13550-015-0109-z
Yamaguchi A, Hanaoka H, Fujisawa Y, Zhao S, Suzue K, Morita A, Tominaga H, Higuchi T, Hisaeda H, Tsushima Y, Kuge Y, Iida Y. Differentiation of malignant tumours from granulomas by using dynamic [(18)F]-fluoro-L-α-methyltyrosine positron emission tomography. EJNMMI Res. 2015 Apr 30;5:29. doi: 10.1186/s13550-015-0109-z. eCollection 2015. PMID: 25977883; PMCID: PMC4420762.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1326 entries